| 2025-11-19 |
详情>>
内部人交易：
TEISSEYRE THOMAS股份减少1405.00股
|
| 2025-11-13 |
详情>>
股本变动：
变动后总股本9716.87万股
|
| 2025-11-13 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.38美元,归母净利润-2966.2万美元,同比去年增长2.20%
|
| 2025-11-13 |
财报披露：
美东时间 2025-11-13 盘后发布财报
|
| 2025-08-13 |
详情>>
业绩披露：
2025年中报每股收益-0.24美元,归母净利润-1864.3万美元,同比去年增长6.80%
|
| 2025-05-13 |
详情>>
业绩披露：
2025年一季报每股收益-0.12美元,归母净利润-941.8万美元,同比去年增长4.37%
|
| 2025-04-07 |
股东大会：
将于2025-05-19召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve one-year terms expiring in 2026;
2.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|
| 2025-03-17 |
详情>>
业绩披露：
2024年年报每股收益-0.56美元,归母净利润-4072万美元,同比去年增长7.95%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.42美元,归母净利润-3033万美元,同比去年增长9.61%
|
| 2024-08-09 |
详情>>
业绩披露：
2024年中报每股收益-0.28美元,归母净利润-2000.4万美元,同比去年增长12.25%
|
| 2024-05-14 |
详情>>
业绩披露：
2024年一季报每股收益-0.14美元,归母净利润-984.8万美元,同比去年增长19.01%
|
| 2024-04-26 |
股东大会：
将于2024-06-11召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve one-year terms expiring in 2025;
2.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To approve a proposed amendment (the “Sunset Amendment”) to our amended and restated certificate of incorporation, as amended, to add a provision with respect to the automatic conversion of our Class B common stock effective December 22, 2028, which is seven years from the date of the closing of our business combination by and among Hyperfine, Inc. (formerly HealthCor Catalio Acquisition Corp.), Optimus Merger Sub I, Inc., Optimus Merger Sub II, Inc., Hyperfine Operations, Inc. (formerly Hyperfine, Inc.) and Liminal Sciences, Inc.;
4.To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|
| 2024-03-22 |
详情>>
业绩披露：
2023年年报每股收益-0.62美元,归母净利润-4423.8万美元,同比去年增长39.54%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.47美元,归母净利润-3355.4万美元,同比去年增长44.17%
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-0.32美元,归母净利润-2279.7万美元,同比去年增长51.43%
|
| 2023-04-24 |
股东大会：
将于2023-06-08召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve one-year terms expiring in 2024;
2.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.To approve a proposed amendment to the Hyperfine, Inc. certificate of incorporation, as amended, to limit the liability of our officers as permitted by recent amendments to Delaware law;
4.To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|
| 2023-01-31 |
复牌提示：
2023-01-31 10:13:02 停牌，复牌日期 2023-01-31 10:18:02
|
| 2022-04-25 |
股东大会：
将于2022-06-08召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve one-year terms expiring in 2023;
2.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|